Bayer

SKYLA

Manufacturer:

Bayer

Skyla HCPCS:

J7301

HCPCS Code Descriptor:

Levonorgestrel-releasing intrauterine contraceptive system (skyla), 13.5 mg

Category:

J Code

Skyla NDCs:

50419-0422-01

Primary Type:

Contraceptive/ Long Acting Reversible

Generic/Specialty Status:

Single-Source

Package Type:

Kit

Route of Administration:

Intrauterine

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Skyla:

SKYLA is a Contraceptive/ Long Acting Reversible drug manufactured by Bayer and administered via the Intrauterine route of administration. The J Code: J7301 is aligned to the drug SKYLA.

ACCESS PRICING AND MORE BY REGISTERING

J7301 Added Date:

January 1, 2014

J7301 Effective Date:

January 1, 2017

J7301 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Skyla billing and coding information.
Skyla patient assistance information can be found through Bayer Patient Assistance at the URL: https://www.patientassistance.bayer.us/
SKYLA prescribing information can be found at the link below:
Information regarding SKYLA’s side effects can be found at MedlinePlus